Joe Jimenez, Aditum Bio co-founder and managing director (Steffen Schmidt/Keystone via AP,file)

Q&A: Joe Jimenez talks about sal­vaging ‘stuck’ drugs and why a sub­stance abuse treat­ment could be worth bil­lions of dol­lars

For four years, for­mer No­var­tis CEO Joe Jimenez and his re­search right-hand, Mark Fish­man, have been run­ning Adi­tum Bio. The Oak­land, CA-based ven­ture firm in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.